Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy
Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.
"One thing that I neglected to include in my talk, but feel that it's pertinent, especially in the primary care space, we have seen an emergence of resistant fungal species, something called Trichophyton Indotineae," Elizabeth Swanson, MD, said in an interview with Patient Care Online. Dr Swanson sat down with Patient Care to discuss her presentation given at the 2025 American Academy of Dermatology Annual Meeting in Orlando. Find out how the emergence of T. indotineae has shifted her treatment strategy in clinical practice in the video above.
For more of our conversation with Dr Swanson about her presentation, "Hot Topics in Pediatric Infectious Skin Conditions," check out:
- Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems
- Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD
- Measles Resurgence and Vaccine Efficacy: A Conversation with Elizabeth Swanson, MD
- Rethinking Shingles in Children: Expert Insights for Primary Care
